- Home
- ATNF vs PMCB Comparison
ATNF vs PMCB Comparison
Compare ATNF & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- PMCB
- Stock Information
- Founded
- ATNF 2016
- PMCB 1996
- Country
- ATNF United States
- PMCB United States
- Employees
- ATNF N/A
- PMCB N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATNF Health Care
- PMCB Health Care
- Exchange
- ATNF Nasdaq
- PMCB Nasdaq
- Market Cap
- ATNF 5.0M
- PMCB 5.8M
- IPO Year
- ATNF N/A
- PMCB N/A
- Fundamental
- Price
- ATNF $4.81
- PMCB $0.97
- Analyst Decision
- ATNF
- PMCB
- Analyst Count
- ATNF 0
- PMCB 0
- Target Price
- ATNF N/A
- PMCB N/A
- AVG Volume (30 Days)
- ATNF 21.8M
- PMCB 111.1K
- Earning Date
- ATNF 07-23-2025
- PMCB 08-11-2025
- Dividend Yield
- ATNF N/A
- PMCB N/A
- EPS Growth
- ATNF N/A
- PMCB N/A
- EPS
- ATNF N/A
- PMCB 3.19
- Revenue
- ATNF N/A
- PMCB N/A
- Revenue This Year
- ATNF N/A
- PMCB N/A
- Revenue Next Year
- ATNF N/A
- PMCB N/A
- P/E Ratio
- ATNF N/A
- PMCB $0.30
- Revenue Growth
- ATNF N/A
- PMCB N/A
- 52 Week Low
- ATNF $0.66
- PMCB $0.80
- 52 Week High
- ATNF $17.75
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- ATNF 50.94
- PMCB 50.93
- Support Level
- ATNF $6.29
- PMCB $0.84
- Resistance Level
- ATNF $7.45
- PMCB $1.13
- Average True Range (ATR)
- ATNF 1.82
- PMCB 0.11
- MACD
- ATNF -0.10
- PMCB 0.01
- Stochastic Oscillator
- ATNF 12.88
- PMCB 51.52
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.